Plain-English translation of NCT07288320 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing an experimental medication called to see if it can help reduce the severe symptoms of a manic episode in people with bipolar I disorder. You would receive either this new medication or a placebo (an inactive pill that looks identical), and researchers would track how well the medication works compared to placebo.
Current treatments for manic episodes don't work well enough for everyone, and doctors need new options to help people recover more quickly and safely. This study aims to see whether this medication offers a better way to manage acute mania.
You likely qualify if…
You likely don't qualify if…
You would be hospitalized as part of your acute care treatment. During the study, you would take either the new medication or a placebo daily while doctors monitor your manic symptoms, safety, and how your body processes the medication. The study involves blood tests and regular assessments to track your progress.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States